Efficacy of a Clinical Algorithm for the Selection of Peripheral Venous Catheters (EACEC)

December 1, 2025 updated by: Consorci Sanitari de l'Alt Penedès i Garraf

Efficacy of a Clinical Algorithm for the Selection of Peripheral Venous Catheters to Reduce the Number of Catheter-Associated Complications in Hospitalized Patients: A Retrospective Cohort Study

The aim of this observational study is to investigate the complications associated with peripheral venous catheterization based on whether a correct or incorrect catheter was used according to a clinical algorithm in patients admitted to an acute care unit. The main question it seeks to answer is:

• Are there fewer complications associated with catheterization when a correct catheter choice is made? Data from patients admitted to the acute care units of the sponsoring study center will be reviewed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

30000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
    • Barcelona
      • Sant Pere de Ribes, Barcelona, Spain, 08810
        • Consorci Sanitari Alt Penedes i Garraf

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients admitted to some acute care unit requiring peripheral venous catheterization

Description

Inclusion Criteria:

  • Admitted to acute care hospital wards.
  • Carriers of a peripheral venous catheter.
  • With the study evaluation criteria documented in their medical records.

Exclusion Criteria:

  • Admitted to gynecology, obstetrics, and pediatrics wards.
  • Admitted to the emergency department and intensive care units

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
appropriate catheter type selection
This group will include all peripheral venous catheterizations for which the appropriate catheter type selection according to the standardized algorithm has been performed
Other: standardized algorithm
standardized algorithm for the correct selection of peripheral venous catheters
inappropriate catheter type selection
This group will include all peripheral venous catheterizations for which an inappropriate catheter type selection according to the standardized algorithm has been performed
Other: standardized algorithm
standardized algorithm for the correct selection of peripheral venous catheters

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Catheters removed due to complications associated with the use of a peripheral venous catheter
Time Frame: Through study completion, an average of 1 year
Percentage of catheters removed due to complications associated with the use of a peripheral venous catheter
Through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Selection of the peripheral venous catheter
Time Frame: Through study completion, an average of 1 year
Correct or incorrect selection of the catheter according to the clinical algorithm. The proportion of correctly selected catheters in relation to the total number of catheters will be calculated.
Through study completion, an average of 1 year
Complications associated with the use of a peripheral venous catheter
Time Frame: Through study completion, an average of 1 year
Number of complications associated with the use of a peripheral venous catheter depending on whether a correct or incorrect selection of the catheter was made according to the clinical algorithm.
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Investigators

  • Principal Investigator: Esther Moreno, CSAPG

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2025

Primary Completion (Actual)

October 31, 2025

Study Completion (Actual)

October 31, 2025

Study Registration Dates

First Submitted

May 21, 2024

First Submitted That Met QC Criteria

May 27, 2024

First Posted (Actual)

May 30, 2024

Study Record Updates

Last Update Posted (Actual)

December 5, 2025

Last Update Submitted That Met QC Criteria

December 1, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CSAPG-47

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).

IPD Sharing Time Frame

After publication of main results of the study.

IPD Sharing Access Criteria

IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe